A case of Bickerstaff's brainstem encephalitis in childhood by Ji Youn Kim et al.
Korean Journal of Pediatrics Vol. 53, No. 4, 2010
DOI : 10.3345/kjp.2010.53.4.607 Case report
- 607 -
1)jtj
Introduction
Bickerstaff's brain stem encephalitis (BBE) is characte-
rized by the acute onset of external ophthalmoplegia, ata-
xia, altered consciousness, and hyperreflexia after the
exclusion for other diseases involving the brain stem
1-3).
In addition, the neurological signs that suggest this abnor-
mality of the central nerves system presents with: abnor-
malities of the pupils, facial weakness, bulbar palsy, dy-
sesthesia, limb weakness, positive Babinski sign, nystag-
mus, and blepharotosis
4).
Most cases have a history of a prior infection such as
Campylobacter jejuni that can be diagnosed by serum IgM,
IgG, and IgA antibody titers to C. jejuni
1-3), an autoim-
mune mechanism produced by microbial infection may
trigger the pathogenesis of BBE
4). The successful use of
plasmapheresis, steroid treatment, intravenous immunoglo-
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bulins (IVIG) for the treatment of BBE suggests an auto-
immune etiology
5, 6). There have been several reports of
BBE associated with antiganglioside antibodies. Anti-GQ1b
antibodies are frequently detected in as much as among 66
% of patients with BBE
4, 7). Other antibodies that may be
positive in patients with BBE are: anti-GM1, anti GD1a,
and anti-Ga1NAc-Gd1a
8). We report a case of BBE with
elevated anti-GM1 antibodies in the serum and CSF in
addition to specific clinical symptoms: a cranial polyneuro-
pathy presenting as ophthalmoplegia, dysarthria, dyspha-
gia, and facial weakness; progressive motor weakness; al-
tered mental status; and ataxia.
Case report
A previously healthy girl, 9 years 6 months of age, pre-
sented to the Chonnam National University Hospital
(CNUH) due to double vision, slurred speech and intermit-
tent ataxia following a fever that was documented once
three days before admission. There were no other asso-
ciated symptoms such as diarrhea, cough, coryza or sore
throat. On the day following admission her both eyelids
became ptotic and the eyes were totally opthalmoplegic.
Both pupils were dilated and fixed without light reflexes.
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= Abstract =
Bickerstaff's brainstem encephalitis (BBE) is a rare disease diagnosed by specific clinical features such as 'progressive,
relatively symmetric external ophthalmoplegia and ataxia by 4 weeks' and 'disturbance of consciousness or hyperreflexia'
after the exclusion of other diseases involving the brain stem. Anti-ganglioside antibodies (GM, GD and GQ) in the serum
or cerebrospinal fluid (CSF) are sometimes informative for the diagnosis of BBE because of the rarity of positive findings
in other diagnositic methods: brain magnetic resonance imaging (MRI), routine CSF examination, motor nerve conduction
study, and needle electromyography. We report a rare case of childhood BBE with elevated anti-GM1 antibodies in the
serum, who had specific clinical symptoms such as a cranial polyneuropathy presenting as ophthalmoplegia, dysarthria,
dysphagia, and facial weakness; progressive motor weakness; altered mental status; and ataxia. However, the brain MRI,
routine CSF examination, nerve conduction studies, electromyography, somatosensory evoked potentials, and brainstem
auditory evoked potentials were normal. BBE was suspected and the patient was successfully treated with intravenous
immunoglobulins. (Korean J Pediatr 2010;53:607-611)
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The patient could not wrinkle her forehead or push her
tongue out. In addition, she was unable to swallow. The
finger-to-nose and heel-to-knee maneuvers were ab-
normal bilaterally. The muscle strength in the extremities
was reduced in the lower to upper limbs and was grade
2-3 on the Medical Research Council Scale. Deep tendon
reflexes were brisk but sensation was intact. The patient
gradually became drowsy and stuporous. The patient rapi-
dly deteriorated over the first two weeks and developed
transient malignant hypertension with seizures on 7
th day.
However, by one month gradual improvement was noted
(Fig. 1).
The routine tests on admission showed no abnormalities
in the complete blood count, blood chemistry (including
plasma glucose, ammonia, electrolytes, C-reactive protein,
pH and bicarbonate), urine analysis and CSF examination.
Additional studies revealed increased levels of IgM and
IgG anti-GM1 antibodies, both in CSF and serum. IgM 3
EU/mL and IgG 3-6 EU/mL (normal, 0 EU/mL), respec-
tively, in the CSF; and IgM 20.32 EU/mL and IgG 32.57
EU/mL (normal, <20 EU/mL), respectively, in the serum.
In addition, there was transient elevation of antistrep-
tolysin O (ASO) (845 IU/mL on admission and 438 IU on
11
th day) in the serum and transient positive mycoplasma
antibodies (1:80) associated with a positive cold agglutinin
test (1:128) in the blood. No abnormal findings were re-
vealed on repeat CSF examination on day 5: stain, culture,
oligoclonal bands, myelin basic protein, IgG and albumin
(including Ig G index), mycoplasma PCR and herpes sim-
plex virus (HSV) PCR. The plasma renin activity (PRA,
Hospital day 1
st 2
nd 3
rd 5
th 6
th 7
th 8
th 10
th 11
th 12
th 13
th 19
th 20
th 23
th 24
th 25
th 37
th
Mental status Alert Drowsy/Stuporous Alert
Muscle strength
Upper (R/L)
Lower (R/L)
G5/G5 G5/G5
G3/G3 G2/G2
G3/G3
G4/G4 G5/G5
G5/G5
G3/G3 G2/G2
G3/G3
G4/G4 G5/G5
Bulbar palsy Dysarthria Dysarthria, dysphagia, facial palsy, respiratory failure Mild facial palsy
Ocular movement Intact Total ophthalmoplegia (external and internal) with ptosis
Limited gaze (+)
DTR (R/L) ++/++ +/+ ++/++
Treatment
IVIG
MethyIPRD
Ventilator care
Fig. 1. Patient hospital course. Abbreviations : R, right; L, left; DTR, deep tendon reflex; G, grade; IVIG, intravenous immunoglobulin;
MethylPRD, methylprednisolone.
Fig. 2. Brain magnetic resonance imaging scan obtained on day 2 shows no abnormal intracra-
nial findings in T1 (A) and T2 (B) weighted images.A case of Bickerstaff’s brainstem encephalitis in childhood
- 609 -
10.5 ng/mL/hr) was transiently increased with the deve-
lopment of malignant hypertension. However, during follow
-up, the PRA and aldosterone levels returned to normal
(1.3 ng/mL/hr and <1.0 ng/dL, respectively). The brain
magnetic resonance imaging (MRI) on admission showed
no abnormalities (Fig. 2). The electroencephalogram was
normal on admission but showed irregular high amplitude
delta wave slow activity during deterioration of the pa-
tient s mental status. However, there were no epileptiform ’
discharges postictally on day 7 when malignant hyperten-
sion was noted (Fig.3). The nerve conduction velocity,
electromyography, somatosensory evoked potentials, brain
stem auditory evoked potentials and visual evoked poten-
tials evaluated during admission in 1 month showed no
abnormal findings.
The patient was diagnosed with brainstem encephalitis
with a bilateral cranial polyneuropathy including the cranial
second, third, fourth, sixth, seventh, ninth, and twelfth
nerves. We treated the patient with intravenous immuno-
globulins (400 mg/kg for 5 days) and methylprednisolone
(for the first 3 days). On day 5 she required the assisted
ventilation until day 18 due to respiratory failure; however,
by day 18 she could be weaned from this respiratory
support. The extraocular nerve palsies, motor weakness
and deep tendon reflexes gradually improved over the next
three weeks. The deep tendon reflexes were weakly
present in all four extremities. The patient was discharged
after 37 days of admission and was followed in the
outpatient clinic with mild limitation of the right lateral gaze
and facial expression. However, all symptoms completely
resolved by about three months after discharge.
Discussion
Bickerstaff and Cloake
1) reported three cases of drowsi-
ness, ophthalmoplegia and ataxia in 1951, and proposed that
the lesion responsible for these clinical signs was in the
midbrain. Bickerstaff
9) reviewed this syndrome for the
handbook of Clinical Neurology under the title of 'brainstem
encephalitis. The diagnostic criteria for BBE include: (1)
progressive, relatively symmetric ophthalmoplegia and
ataxia by four weeks, (2) either altered consciousness
(coma, semicoma or stupor) or pyramidal signs (hyperre-
flexia or pathological reflexes) , and (3) limb strength of 5 or
4 on the Medical Research Council scale
10). The clinical
symptoms of BBE are similar to those of the Fisher syn-
drome (FS); the common features are ophthalmoplegia,
ataxia and CSF albumin-cytological dissociation
10). How-
ever, the diagnosis of BBE must include alteration of con-
sciousness or pyramidal signs, which reflect a serious
brainstem lesion; the FS does not include these charac-
teristics
10).
The etiology of BBE remains unknown. However, one
widely accepted hypothesis suggests an infectious agent
triggers an immunological response
3, 11-15). Bickerstaff and
Cloake
1) speculated that the etiology of BBE is similar to
Fig. 3. The postictal electroencephalography on day 7 shows irregular high
amplitude slow activity without epileptiform discharges.JY Kim, YO Kim, YJ Son, et al.
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that of the Guillain-Barre syndrome (GBS). However, the
relationship between the BBE and the GBS has not yet
been established
4, 6, 10, 16). Various antecedent infections
such as Campylobacter jejuni, cytomegalovirus, Epstein-
Barr virus, Mycoplasma pneumoniae and HSV have been
reported to be linked to GBS
17). BBE also often follows a
viral illness such as cytomegalovirus, varicella zoster
virus, and Epstein-Barr virus
12-14). In our case, the ASO
and mycoplasma antibody titers were transiently elevated
but no symptoms suggesting an infection were present. As
not all the viruses previously reported to be associated
with BBE were tested, it was impossible to conclude that
this case was not associated with an antecedent triggering
infection.
From an immunological perspective, anti-GQ1b IgG
antibodies are frequently detected in the sera of patients
with BBE, GBS and FS, and used to support the clinical
diagnosis
6, 7). Even though anti-GQ1b antibodies have
been most frequently reported in patients with BBE
4, 7),
other antibodies such as anti-GM1, anti GD1a, anti-
Ga1NAc-Gd1a and anti-Campylobacter jejuni antibodies
may also be positive, though less common
8). Matsuo et al.
reported that the IgM antibody titers of GM1b and GalNAc
-GD1a were longitudinally correlated with clinical impro-
vement
18). Our patient had anti-GM1 IgM and IgG anti-
bodies in the serum and CSF. However, other antibodies
related to BBE including anti-GQ1b IgG antibodies were
not tested because they were not commercially available.
Therefore, the data was limited with regard to the other
related antibodies in addition to anti-GM1 IgM and IgG
antibodies.
Brain imaging is rarely useful for the diagnosis of BBE.
Abnormal lesions (high-intensity areas on T2-weighted
images of the brainstem, thalamus, cerebellum and cereb-
rum) on MRI have been reported to be present in only
11% of the patients with BBE
19). During the first week of
illness, CSF albumin-cytological dissociation was reported
in 25% of patients with BBE
19). The EEG showed mostly
slow wave activity in the to range indicating CNS θ δ
involvement, consistent with altered consciousness
4). With
regard to nerve conduction studies, most patients with
BBE were normal
4).
Most patients with BBE are treated with immunothe-
rapy, such as steroids, plasmapheresis and intravenous
immunoglobulin (IVIG); the outcome for patients with BBE
is generally good
16).
In conclusion, we report a rare childhood case of BBE
with a good clinical outcome after successful treatment
with IVIg and methylprednisolone. The diagnosis of BBE in
our case was supported by the specific clinical symptoms
(e.g. cranial polyneuropathy presented as ophthalmoplegia,
dysarthria, dysphagia, and facial weakness; progressive
motor weakness; disturbed mental status; and ataxia) and
the presence of anti-GM1 antibodies in the serum and
CSF.
한 글 요 약
뇌간 뇌염 례 Bickerstaff 1
전남대학교 의과대학 소아과학교실
김지윤 김영옥 손영준 우영종 ㆍ ㆍ ㆍ
뇌간 뇌염은 주 이내의 진행성이며 비 Bickerstaff (BBE) 4 ,
교적 대칭성으로 오는 안근 마비와 실조증 의식 장애 또는 심부 ,
건 반사 항진 등의 임상적 특징을 가지며 뇌간을 침범하는 타 질 ,
환을 배제하였을 때 진단할 수 있는 드문 질환이다 혈청 또는 뇌 .
척수액의 항 항체 는 때로 Ganglioside (GM, GD and GQ) BBE
의 진단에 도움이 되기도 하며 뇌 자기 공명 영상 뇌 척수액 검 , ,
사 신경 전도 검사 및 근 전도 검사 등은 진단에 크게 도움이 되 ,
지 않는다 저자들은 안근 마비 실조증 언어 운동 장애 연하 장 . , , ,
애 점진적 사지 마비 의식 저하 등의 증상을 보이며 혈청과 뇌 , ,
척수액에서 항체의 증가를 보여 로 진단하고 면 anti-GM1 BBE
역 글로불린과 스테로이드 치료 후 완치되었던 세의 여아의 증 9
례를 경험하였기에 문헌 고찰과 함께 이를 보고하는 바이다.
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